98%
921
2 minutes
20
Extracellular vesicles (EVs) have attracted significant scientific attention due to their critical functions in intercellular communication and their possible uses in diverse fields such as immunology, therapeutics, reproductive biology, biotechnology, and medicine. EVs are engulfed in a layer of proteins, also known as protein corona, which is speculated to play roles in several areas, from intercellular communication through immune recognition to cargo delivery. The composition of the protein corona strongly depends on the origin and the biological environment of EVs. Understanding the protein corona opens doors to finding various applications for vesicles by manipulating them. Typical ways of protein corona removal involve applying high salt concentration or the use of surface-active biomolecules, such as peptides, but this can result in EV membrane damage or complete vesicle disruption. Here, we describe a protocol for characterizing the change in protein corona content on red blood cell-derived EVs (REVs) by using linear dichroism spectroscopy (LD) with microfluidic resistive pulse sensing (MRPS). LD can quantify the change in the amount of the surface attached hemoglobins but cannot identify whether these changes are due to vesicle disruption or protein corona removal from intact vesicles. This necessitates the use of MRPS, which counts the number of vesicles before and after adding a surface manipulating compound. Thus it can identify whether the change in LD signal is due to vesicle disruption or due to loss of protein corona. The combined methods can be employed to understand which process takes place in which ratio, allowing the optimization of vesicle engineering toward specific needs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/978-1-0716-4434-8_14 | DOI Listing |
Biomaterials
September 2025
Department of Biomedical Engineering, Program in Genetic Drug Engineering, Department of Biochemistry, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA. Electronic address:
Modular lipid nanoparticles (LNPs) are a promising platform to deliver mRNA to various tissues and cells. Optimization of LNPs for hepatic and extrahepatic tissues often involves substitution of helper lipids or addition of novel lipids not found in conventional four-component LNPs. Among the lipids that comprise LNPs, the functional contributions of phospholipids (PLs) in selective organ targeting (SORT) LNPs remain poorly understood.
View Article and Find Full Text PDFACS Nano
September 2025
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Nanoparticles bind to proteins in cells selectively and form a protein corona around them. However, the mechanisms of protein conformational changes underlying the interactions between nanoparticles and protein coronas remain poorly understood. In this study, we prepared small molecule self-assembled nanoparticles (Aloin NPs) as a research tool to investigate the allosteric mechanism of protein coronas.
View Article and Find Full Text PDFJ Appl Toxicol
September 2025
School of Engineering and Technology, National Forensic Science University, Gandhinagar, India.
Microplastics and nanoplastics (MNPs) are common pollutants that engage with proteins, lipids, nucleic acids, and other biomolecules, damaging cell structure. This review goes beyond simply listing where MNPs are found to explore how they cause harm, detailing mechanisms such as oxidative stress, endocrine disruption, genotoxicity, protein misfolding, lipid membrane destabilization, and epigenetic changes. Propose an integrated mechanistic hypothesis connecting these processes via oxidative epigenetic feedback loops, size-dependent organelle targeting, and pollutant corona effects, with potential implications for cellular aging and transgenerational outcomes.
View Article and Find Full Text PDFJ Comput Chem
September 2025
Johnson & Johnson, Beerse, Belgium.
Herein we report the in silico discovery of 13 novel micromolar potent inhibitors of the SARS-CoV-2 NSP13 helicase validated in cellular antiviral and biophysical ThermoFluor assays. The compounds, discovered using a novel fragment-based pharmacophore virtual screening workflow named FragmentScout, enable the advancement of novel antiviral agents. FragmentScout uses publicly accessible structural data of the SARS-CoV-2 NSP13 helicase, which was previously generated at the Diamond LightSource by XChem high-throughput crystallographic fragment screening.
View Article and Find Full Text PDFEur J Pain
October 2025
Headache Science and Neurorehabilitation Unit, IRCCS Mondino Foundation, Pavia, Italy.
Background: Although robust genetic markers for episodic migraine (EM) have been identified, variants associated with chronic migraine (CM) are still unknown. Given the potential pathophysiologic overlap between EM and CM, we investigated whether six single nucleotide polymorphisms (SNPs), robustly associated with EM susceptibility (LRP1 rs11172113, PRDM16 rs10797381, FHL5 rs7775721, TRPM8 rs10166942, near TSPAN2 rs2078371 and MEF2D rs1925950) also play a role in the risk of developing CM.
Methods: A total of 200 EM and 202 CM participants were prospectively included.